{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:04:37Z","timestamp":1790618677395,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Interstitial lung disease (ILD) is a common complication in patients with common variable immunodeficiency (CVID) and often associated with other features, such as bronchiectasis and autoimmunity. As the ILD term encompasses different acute and chronic pulmonary conditions, the diagnosis is commonly made based on imaging features; histopathology is less frequently available. From a cohort of 637 patients with CVID followed at our center over 4 decades, we reviewed the data for 46 subjects (30 females, 16 males) who had lung biopsies with proven ILD. They had a median age at CVID diagnosis of 26 years old, with a median IgG level at diagnosis of 285.0 mg\/dL with average isotype switched memory B cells of 0.5%. Lung biopsy pathology revealed granulomas in 25 patients (54.4%), lymphoid interstitial pneumonia in 13 patients (28.3%), lymphoid hyperplasia not otherwise specified in 7 patients (15.2%), cryptogenic organizing pneumonia in 7 patients (15.2%), follicular bronchitis in 4 patients (8.7%), and predominance of pulmonary fibrosis in 4 patients (8.7%). Autoimmune manifestations were common and were present in 28 (60.9%) patients. Nine patients (19.6%) died, with a median age at death of 49-years-old. Lung transplant was done in 3 of these patients (6.5%) who are no longer alive. These analyses reveal the high burden of this complication, with almost one-fifth of the group deceased in this period. Further understanding of the causes of the development and progression of ILD in CVID patients is required to define the best management for this patient population.<\/jats:p>","DOI":"10.3389\/fimmu.2021.605945","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:06:30Z","timestamp":1615421190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Interstitial Lung Disease in Common Variable Immunodeficiency"],"prefix":"10.3389","volume":"12","author":[{"given":"Joao Pedro","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-en","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaip.2018.12.004","article-title":"Differentiation of common variable immunodeficiency from IgG deficiency","volume":"7","author":"Filion","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.iac.2020.03.002","article-title":"The importance of primary immune deficiency registries: the United States immunodeficiency network registry","volume":"40","author":"Lopes","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12728","article-title":"Common variable immune deficiency: dissection of the variable","volume":"287","author":"Cunningham-Rundles","year":"2019","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.anai.2019.07.014","article-title":"Autoimmunity in common variable immunodeficiency","volume":"123","author":"Agarwal","year":"2019","journal-title":"Annals Allergy Asthma Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1182\/blood.2019002062","article-title":"Common variable immune deficiency: case studies","volume":"134","author":"Cunningham-Rundles","year":"2019","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fimmu.2012.00189","article-title":"Autoimmune cytopenias in common variable immunodeficiency","volume":"3","author":"Podjasek","year":"2012","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10875-017-0456-9","article-title":"Autoimmune cytopenias and associated conditions in CVID: a report From the USIDNET registry","volume":"38","author":"Feuille","year":"2018","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"h2072","DOI":"10.1136\/bmj.h2072","article-title":"The diagnosis and management of interstitial lung diseases","volume":"350","author":"Wallis","year":"2015","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American thoracic society\/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.anai.2017.03.003","article-title":"Can we effectively use radiographic imaging and clinical parameters for making an earlier diagnosis of granulomatous interstitial lung disease in patients with common variable immunodeficiency?","volume":"118","author":"Harville","year":"2017","journal-title":"Annals Allergy Asthma Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10875-019-00708-2","article-title":"Interstitial lung disease frequently precedes CVID diagnosis","volume":"39","author":"Hanitsch","year":"2019","journal-title":"J Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-019-00657-w","article-title":"Cellular defects in CVID patients with chronic lung disease in the USIDNET registry","volume":"39","author":"Kellner","year":"2019","journal-title":"J Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaip.2015.07.004","article-title":"Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings","volume":"3","author":"Maglione","year":"2015","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.anai.2014.04.024","article-title":"Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations","volume":"113","author":"Maglione","year":"2014","journal-title":"Annals Allergy Asthma Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clim.2009.10.002","article-title":"Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)","volume":"134","author":"Park","year":"2010","journal-title":"Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1513\/AnnalsATS.201511-728OC","article-title":"Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease","volume":"13","author":"Mannina","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10875-019-00640-5","article-title":"Factors beyond lack of antibody govern pulmonary complications in primary antibody deficiency","volume":"39","author":"Weinberger","year":"2019","journal-title":"J Clin Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaip.2017.01.021","article-title":"British lung foundation\/United Kingdom primary immunodeficiency network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders","volume":"5","author":"Hurst","year":"2017","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.18176\/jiaci.0450","article-title":"Rituximab as a single agent for granulomatous lymphocytic interstitial lung disease in common variable immune deficiency","volume":"29","author":"Tessarin","year":"2019","journal-title":"J Investig Allergol Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccm.2019.05.004","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"40","author":"Long","year":"2019","journal-title":"Clin Chest Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.humpath.2015.05.011","article-title":"Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency\u2013histologic and immunohistochemical analyses of 16 cases","volume":"46","author":"Rao","year":"2015","journal-title":"Hum Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cei.13343","article-title":"Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?","volume":"198","author":"Patel","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s10875-014-0068-6","article-title":"CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters","volume":"34","author":"Maarschalk-Ellerbroek","year":"2014","journal-title":"J Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e122728","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"key":"B33","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.anai.2017.01.004","article-title":"Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"118","author":"Hartono","year":"2017","journal-title":"Annals Allergy Asthma Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"133","author":"Ardeniz","year":"2009","journal-title":"Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.chest.2019.01.034","article-title":"Rituximab monotherapy for common variable immune deficiency-associated granulomatous-lymphocytic interstitial lung disease","volume":"155","author":"Ng","year":"2019","journal-title":"Chest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jaip.2018.10.041","article-title":"Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency","volume":"7","author":"Cereser","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B37","first-page":"203","article-title":"Steroids: pharmacology, complications, and practice delivery issues","volume":"14","author":"Ericson-Neilsen","year":"2014","journal-title":"Ochsner J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.40114","article-title":"Mycophenolate mofetil versus placebo for systemic sclerosis-related interstitial lung disease: an analysis of scleroderma lung studies I and II","volume":"69","author":"Volkmann","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.chest.2019.05.023","article-title":"Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease","volume":"156","author":"Huapaya","year":"2019","journal-title":"Chest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11926-018-0731-7","article-title":"Management of interstitial lung disease in patients with myositis specific autoantibodies","volume":"20","author":"Mecoli","year":"2018","journal-title":"Curr Rheumatol Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.21037\/jtd.2017.07.85","article-title":"Outcomes after lung transplantation","volume":"9","author":"Thabut","year":"2017","journal-title":"J Thorac Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1073\/pnas.1808403116","article-title":"Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysis","volume":"116","author":"Maffucci","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/ACI.0b013e32835914b9","article-title":"The many faces of the clinical picture of common variable immune deficiency","volume":"12","author":"Resnick","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1182\/blood.2019000929","article-title":"Current genetic landscape in common variable immune deficiency","volume":"135","author":"Abolhassani","year":"2020","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.605945\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:06:33Z","timestamp":1615421193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.605945\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2021.605945"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.605945","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"article-number":"605945"}}